CA Stock MarketDetailed Quotes

MDNA Medicenna Therapeutics Corp

Watchlist
  • 1.670
  • 0.0000.00%
15min DelayTrading Nov 25 16:00 ET
128.66MMarket Cap-4394P/E (TTM)

About Medicenna Therapeutics Corp Company

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.

Company Profile

SymbolMDNA
Company NameMedicenna Therapeutics Corp
Founded2015
MarketTSE
Employees19
Fiscal Year Ends03-31
Address2 Bloor Street W. 7th Floor
CityToronto
CountryCAN
Zip CodeM4W 3E2
Websitehttps://www.medicenna.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Fahar Merchant,PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 877.19K
  • Rosemina Merchant
  • Chief Development Officer
  • 613.71K
  • David Hyman
  • Chief Financial Officer
  • --
  • Karen A. Dawes, M.A.
  • Independent Director
  • 123.70K
  • Karim Lalji
  • Independent Director
  • --
  • Dr. John H. Sampson, M.B.A.,M.D.,PhD
  • Independent Director
  • 111.83K
  • Albert Beraldo, C.A.,C.P.A.
  • Lead Independent Director
  • 142.95K
  • Dr. John Geltosky, PhD
  • Independent Director
  • 117.45K
Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data